Loading data
CRNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.31 bn USD | 2.13 bn USD | 1.86 bn USD | 1.78 bn USD | 2.06 bn USD |
| Cost of revenue | 1.33 bn USD | 1.26 bn USD | 1.11 bn USD | 1.12 bn USD | 1.37 bn USD |
| Gross profit | — | 867.8 m USD | 751 m USD | — | — |
| Research and development expense | 47.8 m USD | 46.1 m USD | 54.8 m USD | 48.3 m USD | 49.5 m USD |
| Selling, general and administrative expense | — | 512 m USD | 500.6 m USD | 493.5 m USD | 467.1 m USD |
| Operating profit | 424.2 m USD | 355.8 m USD | 250.4 m USD | 5.3 m USD | 221.7 m USD |
| Interest expense | — | — | 22.7 m USD | 10.1 m USD | 4.9 m USD |
| Profit before tax | 432.8 m USD | 338.5 m USD | 233.1 m USD | 236.5 m USD | 233.7 m USD |
| Income tax expense | 101.1 m USD | 70.3 m USD | 57.2 m USD | 70.1 m USD | 36.3 m USD |
| Net income (reported basis) | 331.7 m USD | 268.2 m USD | 203.8 m USD | 401.1 m USD | 435.4 m USD |
| Basic earnings per share | 6.38 USD/share | 5.15 USD/share | 4.51 USD/share | 7.11 USD/share | 7.46 USD/share |
| Diluted earnings per share | 6.26 USD/share | 5.05 USD/share | 4.45 USD/share | 7.01 USD/share | 7.36 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.